We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Genedrive Plc | GDR | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.45 | 15:33:30 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.45 | 2.425 | 2.45 | 2.45 | 2.45 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 27/12/2024 11:25 by faraweigh2 Suitors interest levels are increasing.Great RNS update.Immensely upbeat 2025 for GDR and their investors. |
Posted at 02/12/2024 21:42 by hazl It was stated on the investors meet how much they get through every month.So with the remaining cash, that will keep them going until April /May. He spoke about the possibility of grant funding and so on from memory. Already babies hearing has been saved, since this has been used. There are 100,000 strokes in the UK every year. A surprising fact is that in the ME there are regularly younger people having strokes,too. Clopidogrel needs to be broken down by the gene CYP2C19 to work. There seems a higher incidence of DNA variants in certain countries and there seems to be a keeness for our governments to support under represented groups, which goes in GDR favour. I think whatever the time scale we as investors are onto a win, here. And I personally am not worried at the exaggerations of some. I also feel priviledged to be part of such a very good thing to do for people. Who knows which of us might be touched in some way, by the need for these things? Or indeed our families? imo IMO |
Posted at 26/11/2024 19:09 by batiatus I find it hilarious and childish for all the down ticks.What are these down ticks meant to achieve exactly... To discredit me? To fool new investors? Or simply denialing the facts? It will only make the board looks silly. Potential investors come on here and they will be turned away by the mob culture LOL!!! Let's see if I can get 3 down ticks for this post. Keep them coming!!! |
Posted at 23/11/2024 18:13 by indomie1 This company clearly has enviable links into both the Manchester genomic health innovation cluster and the NHS and it has rec'd financial backing from the public sector, who see benefits in the products coming to market. However, GDR also has an investor problem. Many are very very short term small investors whose interests are not aligned with the long term success of the business and its products.I have no idea why so many of these firms get snapped up by overseas buyers and don't attract strong institutional shareholder bases, but surely now is the time for the Board to hold a strategic review to tease out proposals from the market when it is in a strong position to consider them against the standalone, shareholder funded option? There are lots of options, licensing deals for certain territories or convertible loan finance, which have various benefits and disadvantages, but its not really clear at present how GDR will scale up quickly enough to take advantage of this massive opportunity! |
Posted at 23/11/2024 15:24 by indomie1 GDR is in a closed period, so limited in what can say until results day.PALOH UK award is very positive for future UK rollout, although has started a month later than flagged in last results and could be completed early. Given the former CEO indicated MT-RNR1 national commissioning would start in April 2025, the details of this award suggest this was way off the mark and may well have contributed to decision to leave the business. The strategic pivot to POC pharmacogenomic testing appears to be gaining traction, but the commercial rollout is likely to be slower than anticipated (in England at least), which is weighing on share price Find it difficult to understand the Board's financing strategy given the inherent risks around timeline to break even. Investors who haven't participated in past funding rounds will likely never recover losses, and tens of millions of pounds have been sunk into the company, some obtained at very high cost to existing investors. GDR doesnt just need a route to profitability, where is the strategic investor who can support global product distribution and marketing or provide support on commercialisation plans? Uncertainty remains over Board succession planning, given existing NEDs have been in post for some considerable time and the Chair is no longer considered independent as has served over 9 years. GDR still have access to an (expensive) credit facility with about £1.5m left with Riverfort, if needed. How many binding or non binding expressions of interest have been received for either test, subject to regulatory approvals, given marketing activity to date? |
Posted at 19/11/2024 10:30 by kingston78 So many small AIMS companies could only muster a placing of shares raising only £1 million or less in difficult markets. There is little appetite of retail investors. £1 million does not last for long for administrative expenses (including salary and usual overheads). There is little left for development of its products or services.There will be little or no progress for the company as a whole. The company will keep on raising more money via further discounted placing, diluting existing investors. The cycle repeats itself. That is the reality. Such companies can dream on; only a tiny minority of them will make it and become successful. |
Posted at 03/11/2024 18:56 by premium beeks Yes, a lot of pie in the sky on here today. But why not eh? I don't think we invested here for a 10% rise - we've already seen how the price can react on news, it often goes up multiples. Meanwhile Bataitus talks of the company doing nothing for months - really? Where's your proof?Sadly many investors don't understand that to us it's a profit or loss and a move on at some point. To others it's a job, a career, a life's work wanting to make other people's lives better. Until you understand both sides you'll never be an investor, just a gambler. |
Posted at 20/7/2024 07:43 by z1co Look what the idiot posts:Batiatus19 Jul '24 - 17:18 - 6263 of 6300 0 7 1 ProfessoraAim and Z1co, Both two faced cxxts with no moral It seems they have realized the dangerous position they are in. Experienced investors never hold over weekend and have sold out. -------------------- LOLOL "Experienced investors never hold over weekend and have sold out." What the idiot really means is that TRADERS never hold over the weekend. Hey THICKO investors hold their shares for a very LONG time and that includes weekends as well YOU'RE JUST A SMALL TIME TRADER THAT BUYS ABOUT £1000 worth of shares like purple11 |
Posted at 13/7/2024 06:24 by john henry Z1CO you obviously didnt understand the content of my post.I said the share price would retest the break area around 2p it actually retested 2.025p before moving. where in fact ive added further. Technically ive called this correct. However as your not a Technical chartist i dont expect you to understand the term TAG The move Higher above 2p is investors getting on board in anticipation of a positive NICE review therefore the Market( Investors) are discounting positive news. Imho Investors will discount to around 3p plus until actual news appears. |
Posted at 17/5/2024 13:33 by jaknife kingston78,"There are always insiders or people who know something about it, short selling to drive the price down." The only problem with that thesis is that there is exactly 0% short interest in Genedrive: There is no material short interest, which shouldn't be a surprise because: 1. Genedrive is a tiny market cap and hedge funds short large companies, not small ones. 2. There is negligible institutional interest in Genedrive! Something like 97% of the stock is held by retail investors and, as every well-informed investor will tell you, it is impossible to borrow shares from ordinary retail investors in the UK - you can only borrow stock from professional institutional investors! So given that we've discounted shorters that leaves the real culprits of the share price decline as ... the sensible sane long investors who long ago realised what a pile of sh-one-t Genedrive was and sold their shares! JakNife |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
